BioMarin Pharmaceutical Inc. buy StockNews.com
Start price
22.02.25
/
50%
€65.26
Target price
22.02.26
-
Performance (%)
-30.43%
Price
12.12.25
€45.40
Summary
This prediction is currently active. The BUY prediction by StockNews_com for BioMarin Pharmaceutical Inc. is performing very badly with a performance of -30.43%. This prediction currently runs until 22.02.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -1.003% | -1.003% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by StockNews_com for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by StockNews_com for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€66.60
10.03.25
10.03.25
-
10.03.26
10.03.26
-31.83%
12.12.25
12.12.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€67.70
02.03.25
02.03.25
-
02.03.26
02.03.26
-32.94%
12.12.25
12.12.25
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€88.08
29.04.23
29.04.23
-
29.04.24
29.04.24
-13.03%
30.04.24
30.04.24